Perioperative management of medications used in the treatment of rheumatoid arthritis

HSS Journal

Volumn 2, Issue 2, 2006, Pages 141-147

  Scanzello, Carla R ^a   Figgie, Mark P ^a   Nestor, Bryan J ^a   Goodman, Susan M ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

Anti TNF; Corticosteroids; Methotrexate; Perioperative management; Rheumatoid arthritis; Rituximab

Indexed keywords

EID: 33748289504     PISSN: 15563316     EISSN: 15563324     Source Type: Journal    
DOI: 10.1007/s11420-006-9012-5     Document Type: Article

References (43)

1. An YH, Friedman RJ (1996) Prevention of sepsis in total joint arthroplasty. J Hosp Infect 33:93-108
2. Schlaghecke R, Kornely E, Santen RT, Ridderskamp P (1992) The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone. N Engl J Med 326:226-230
3. McPhee IB, Williams RP, Swanson CE (1998) Factors influencing wound healing after surgery for metastatic disease of the spine. Spine 23:726-732
4. Busti AJ, Hooper JS, Amaya CJ, Kazi S (2005) Effects of perioperative anti-inflammatory and immunomodulating therapy on surgical wound healing. Pharmacotherapy 25:1566-1591
5. Mathis AS, Shah NK, Mulgaonkar S (2004) Stress dose steroids in renal transplant patients undergoing lymphocele surgery. Transplant Proc 36:3042-3045
6. Bromberg JS, Alfrey EJ, Barker CF et al (1991) Adrenal suppression and steroid supplementation in renal transplant recipients. Transplantation 51:385-390
7. Glowniak JV, Loriaux DL (1997) A double-blind study of perioperative steroid requirements in secondary adrenal insufficiency. Surgery 121:123-129
8. Leopold SS, Casnellie MT, Warme WJ et al (2003) Endogenous cortisol production in response to knee arthroscopy and total knee arthroplasty. J Bone Jt Surg Am Vol 85-A:2163-2167
9. Bruewer M, Utech M, Rijcken EJ et al (2003) Preoperative steroid administration: effect on morbidity among patients undergoing intestinal bowel resection for Crohns disease. World J Surg 27:1306-1310
10. Aberra FN, Lewis JD, Mass D et al (2003) Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. Gastroenterology 125:320-327
11. Jain A, Witbreuk M, Ball C, Nanchahal J (2002) Influence of steroids and methotrexate on wound complications after elective rheumatoid hand and wrist surgery. J Hand Surg [Am] 27:449-455
12. Hanssen AD, Cabanela ME, Michel CJ Jr (1987) Hip arthroplasty in patients with systemic lupus erythematosus. J Bone Jt Surg Am Vol 69:807-814
13. Levitsky J, Te HS, Cohen SM (2003) The safety and outcome of joint replacement surgery in liver transplant recipients. Liver Transplant 9:373-376
14. Cronstein BN (2005) Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis. Pharmacol Rev 57:163-172
15. Choi HK, Heman MA, Seeger JD et al (2002) Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 359:1173-1177
16. Pincus T, Yazici Y, Sokka T et al (2003) Methotrexate as the "anchor drug" for the treatment of early rheumatoid arthritis. Clin Exp Rheumatol 21:S179-S185
17. Grennan DM, Gray J, Loudon J, Fear S (2001) Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Ann Rheum Dis 60:214-217
18. Sany J, Anaya JM, Canovas F et al (1993) Influence of methotrexate on the frequency of postoperative infectious complications in patients with rheumatoid arthritis. J Rheumatol 20:1129-1132
19. Carpenter MT, West SG, Vogelgesang SA, Casey Jones DE (1996) Postoperative joint infections in rheumatoid arthritis patients on methotrexate therapy. Orthopedics 19:207-210
20. Bibbo C, Anderson RB, Davis WH, Norton J (2003) The influence of rheumatoid chemotherapy, age, and presence of rheumatoid nodules on postoperative complications in rheumatoid foot and ankle surgery: analysis of 725 procedures in 104 patients. Foot Ankle Int 24:40-44
21. Bland KI, Palin WE, von Fraunhofer JA et al (1984) Experimental and clinical observations of the effects of cytotoxic chemotherapeutic drugs on wound healing. Ann Surg 199:782-790
22. Cohen SC, Gabelnick HL, Johnson RK, Goldin A (1975) Effects of antineoplastic agents on wound healing in mice. Surgery 78:238-244
23. Hernigou P, Thiery JP, Benoit J et al (1989) Methotrexate diffusion from acrylic cement. Local chemotherapy for bone tumours. J Bone Jt Surg Br 71:804-811
24. Shamberger RC, Devereux DF, Brennan MF (1981) The effect of chemotherapeutic agents on wound healing. Int Adv Surg Oncol 4:15-58
25. Kasdan ML, June L (1993) Postoperative results of rheumatoid arthritis patients on methotrexate at the time of reconstructive surgery of the hand. Orthopedics 16:1233-1235
26. Lim V, Pande I (2002) Leflunomide can potentiate the anticoagulant effect of warfarin. BMJ 325:1333,
27. Feldmann MM, Maini RN (2002) Discovery of TNF-α as a therapeutic target in rheumatoid arthritis: preclinical and clinical studies. Joint, Bone, Spine 69:12-18
28. Hochberg MC, Tracy JK, Hawkins-Holt M, Flores RH (2003) Comparison of the efficacy of the tumour necrosis factor α blocking agents adalimumab, etanercept, and infliximab when added to methotrexate in patients with active rheumatoid arthritis. Ann Rheum Dis 62(Suppl 2); ii13-ii16
29. Lipsky PE, van der Heijde DM, St Clair EW et al (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. NEJM 343:1594-1602
30. Hyrich KL, Silman AJ, Watson KD, Symmons DP (2004) Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety. Ann Rheum Dis 63:1538-1543
31. Fisher CJ, Agosti JM, Opal SM et al (1996) Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. NEJM 334:1697-1702
32. Marchai L, D'Haens G, Van Assche G et al (2004) The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study. Aliment Pharmacol Ther 19:749-754
33. Colombel JF, Loftus EV Jr, Tremaine WJ et al (2004) Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol 99:878-883
34. Bibbo C, Goldberg JW (2004) Infectious and healing complications after elective orthopaedic foot and ankle surgery during tumor necrosis factor-alpha inhibition therapy. Foot Ankle Int 25:331-335
35. Giles JT, Bartlett SJ, Gelber AC et al (2006) Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in Rheumatoid Arthritis. Arthritis Care Res 55:333-337
36. Kawaguchi HH, Hizuta AA, Tanaka NN, Orita KK (1995) Role of endotoxin in wound healing impairment. Res Commun Mol Pathol Pharmacol 89:317-327
37. Doran MF, Crowson CS, Pond GR et al (2002) Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 46:2287-2293
38. Edwards JC, Szczepanski L, Szechinski J et al (2004) Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis, NEJM 350:2572-2581
39. White CA, Weaver RL, Grillo-Lopez AJ (2001) Antibody-targeted immunotherapy for treatment of malignancy. Annu Rev Med 52:125-145
40. Sarrecchia C, Cappelli A, Aiello P (2005) HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb. J Infect Chemother 11:189-191
41. Law JK, Ho JK, Hoskins PJ et al (2005) Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: potential implications for future prophylaxis recommendations. Leuk Lymphoma 46:1085-1089
42. Tsutsumi Y, Kanamori H, Mon A et al (2005) Reactivation of hepatitis B virus with rituximab, Expert Opin Drug Safety 4:599-608
43. Cambridge G, Leandro MJ, Edwards JC et al (2003) Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis. Arthritis Rheum 48:2146-2154